Çѱ¹¾î ¹ø¿ªº» Assessment of SpondyloArthritis International Society-Health Index¿¡ ´ëÇÑ ÀÓ»óÀû À¯È¿¼º Æò°¡
Study on Clinical Effectiveness of the Korean Version of Assessment of SpondyloArthritis International Society-Health Index
´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö 2014³â 21±Ç 4È£ p.187 ~ p.191
ÃÖÁ¤È£(Choi Jung-Ho) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ·ù¸¶Æ¼½º³»°úÇб³½Ç
Á¤ÇöÁÖ(Jung Hyun-Ju) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ·ù¸¶Æ¼½º³»°úÇб³½Ç
¿ÀÅ·Å(Oh Tae-Ryom) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ·ù¸¶Æ¼½º³»°úÇб³½Ç
À̽ÂÈÆ(Lee Seung-Hun) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ·ù¸¶Æ¼½º³»°úÇб³½Ç
ÁøÁØ(Jin Joon) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ·ù¸¶Æ¼½º³»°úÇб³½Ç
ÀÌÁ¤¿ø(Lee Jeong-Won) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ·ù¸¶Æ¼½º³»°úÇб³½Ç
ÀÌ°æÀº(Lee Kyung-Eun) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ·ù¸¶Æ¼½º³»°úÇб³½Ç
¹Úµ¿Áø(Park Dong-Jin) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ·ù¸¶Æ¼½º³»°úÇб³½Ç
¹Ú¿ë¿í(Park Yong-Wook) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ·ù¸¶Æ¼½º³»°úÇб³½Ç
À̽ż®(Lee Shin-Seok) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ·ù¸¶Æ¼½º³»°úÇб³½Ç
±èÅÂÁ¾(Kim Tae-Jong) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ·ù¸¶Æ¼½º³»°úÇб³½Ç
Abstract
Objective: To evaluate the validity of the Korean version of ASAS-HI in patients with spondyloarthritis in Korea.
Methods: A total of 91 patients were enrolled. We eval-uated the validity by calculating the correlation co-efficients between the Korean version of ASAS-HI and other clinical parameters, including patient global assess-ment (PGA), spinal back pain score, Bath ankylosing spon-dylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI), ankylosing spondyli-tis disease activity score (AS-DAS), work productivity and activity impairment (WPAI) number 5 and number 6, hos-pital Anxiety and Depression Scale (HADS), health Survey Short-Form 36 (SF-36), and EuroQol visual analogue scale (EQ-5D VAS). Using a Pearson correlation coefficient, the validity was assessed by making a comparison between the correlation of the ASAS HI and clinical parameters in all patients.
Results: The Korean version of ASAS-HI score was corre-lated with PGA, spinal back pain score, BASDAI, BASFI, AS-DAS, WPAI number 5, WPAI number 6, HADS, and EQ-5D (r=0.331, 0.403, 0.638, 0.500, 0.595, 0.480, 0.573, 0.626, ?0.497, p=0.002, £¼0.001, £¼0.001, £¼0.001, £¼0.001, £¼0.001, £¼0.001, and £¼0.001, respectively).
Conclusion: In this study, the clinical effectiveness of the Korean version of ASAS-HI was proved by calculating the correlation with other clinical parameters. The Korean version of ASAS-HI can be used in clinical practice and research to assess the healthy state of spondyloarthritis pa-tients in Korea.
Å°¿öµå
Spondylitis, Ankylosing, Patient outcome as-sessment
KMID :
0388220140210040187
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)